Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cost-consequence Analysis of Intrapartum Streptococcal B Detection by PCR Versus Antenatal Culture at 35-38 SA in the Optimization of Intrapartum Antibiotic Prophylaxis

NCT05005169 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT05005169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05005169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cost-consequence Analysis of Intrapartum Streptococcal B Detection by PCR Versus Antenatal Culture at 35-38 SA in the Optimization of Intrapartum Antibiotic Prophylaxis
Lead sponsor
Nantes University Hospital
Phase
Not applicable
Overall status
Completed
Start date
November 2, 2021
Completion date
May 24, 2023
Enrollment
3,321 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

streptococcus agalactiae